CARM – carisma therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Is There An Opportunity With Carisma Therapeutics, Inc.'s (NASDAQ:CARM) 46% Undervaluation? [Yahoo! Finance]
Carisma Therapeutics, Inc. (NASDAQ: CARM) had its price target lowered by analysts at HC Wainwright from $9.00 to $8.00. They now have a "buy" rating on the stock.
Carisma Therapeutics Inc. (CARM) Reports Q1 Loss, Misses Revenue Estimates [Yahoo! Finance]
Carisma Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights [Yahoo! Finance]
Carisma Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights
Form 10-Q Carisma Therapeutics For: Mar 31
Form 8-K Carisma Therapeutics For: May 09
Form ARS Carisma Therapeutics For: Dec 31
Form DEF 14A Carisma Therapeutics For: Jun 13
Form 8-K Carisma Therapeutics For: Apr 10
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.